Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6S43

Fumarate hydratase of Mycobacterium tuberculosis in complex with formate and allosteric modulator N-(5-(Azocan-1-ylsulfonyl)-2-methoxyphenyl)-2-(4-oxo-3,4-dihydrophthalazin-1-yl)acetamide

6S43 の概要
エントリーDOI10.2210/pdb6s43/pdb
分子名称Fumarate hydratase class II, ~{N}-[5-(azocan-1-ylsulfonyl)-2-methoxy-phenyl]-2-(4-oxidanylidene-3~{H}-phthalazin-1-yl)ethanamide, FORMIC ACID, ... (5 entities in total)
機能のキーワードfumarate hydratase, fumarase, lyase
由来する生物種Mycobacterium tuberculosis
タンパク質・核酸の鎖数4
化学式量合計201830.99
構造登録者
Whitehouse, A.J.,Libardo, M.D.,Kasbekar, M.,Brear, P.,Fischer, G.,Thomas, C.J.,Barry, C.E.,Boshoff, H.I.,Coyne, A.G.,Abell, C. (登録日: 2019-06-26, 公開日: 2019-09-25, 最終更新日: 2024-01-24)
主引用文献Whitehouse, A.J.,Libardo, M.D.J.,Kasbekar, M.,Brear, P.D.,Fischer, G.,Thomas, C.J.,Barry 3rd, C.E.,Boshoff, H.I.M.,Coyne, A.G.,Abell, C.
Targeting of Fumarate Hydratase fromMycobacterium tuberculosisUsing Allosteric Inhibitors with a Dimeric-Binding Mode.
J.Med.Chem., 62:10586-10604, 2019
Cited by
PubMed Abstract: With the growing worldwide prevalence of antibiotic-resistant strains of tuberculosis (TB), new targets are urgently required for the development of treatments with novel modes of action. Fumarate hydratase (fumarase), a vulnerable component of the citric acid cycle in (), is a metabolic target that could satisfy this unmet demand. A key challenge in the targeting of fumarase is its similarity to the human homolog, which shares an identical active site. A potential solution to this selectivity problem was previously found in a high-throughput screening hit that binds in a nonconserved allosteric site. In this work, a structure-activity relationship study was carried out with the determination of further structural biology on the lead series, affording derivatives with sub-micromolar inhibition. Further, the screening of this series against in vitro identified compounds with potent minimum inhibitory concentrations.
PubMed: 31517489
DOI: 10.1021/acs.jmedchem.9b01203
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.42 Å)
構造検証レポート
Validation report summary of 6s43
検証レポート(詳細版)ダウンロードをダウンロード

246704

件を2025-12-24に公開中

PDB statisticsPDBj update infoContact PDBjnumon